Terms: = Breast cancer AND WAS, P42768, 7454, ENSG00000015285, WASP, THC, IMD2
132 results:
1. Efficacy and mechanisms of cannabis oil for alleviating side effects of breast cancer chemotherapy (CBC2): protocol for randomized controlled trial.
Thu MS; Pongpirul K; Vongsaisuwon M; Vinayanuwattikun C; Banchuen K; Ondee T; Payungporn S; Phutrakool P; Nootim P; Chariyavilaskul P; Cherdchom S; Wanaratna K; Hirankarn N
BMC Complement Med Ther; 2024 Mar; 24(1):130. PubMed ID: 38521934
[TBL] [Abstract] [Full Text] [Related]
2. Associations between lifestyle, health, and clinical characteristics and circulating oxysterols and cholesterol precursors in women diagnosed with breast cancer: a cross-sectional study.
Decker NS; Johnson T; Le Cornet C; Behrens S; Obi N; Kaaks R; Chang-Claude J; Fortner RT
Sci Rep; 2024 Feb; 14(1):4977. PubMed ID: 38424253
[TBL] [Abstract] [Full Text] [Related]
3. Cannabidiol Combination Enhances Photodynamic Therapy Effects on MCF-7 breast cancer Cells.
Mokoena D; George BP; Abrahamse H
Cells; 2024 Jan; 13(2):. PubMed ID: 38247877
[No Abstract] [Full Text] [Related]
4. A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER+ breast cancer.
Wang B; Ma M; Dai Y; Yu P; Ye L; Wang W; Sha C; Yang H; Yang Y; Zhu Y; Dong L; Wei S; Wang L; Tian J; Wang H
Eur J Med Chem; 2024 Jan; 264():115934. PubMed ID: 38007911
[TBL] [Abstract] [Full Text] [Related]
5. The effects of adding palbociclib to endocrine therapy to treat advanced breast cancer: a plain language summary of a study using the PALOMA-2 and PALOMA-3 trial results.
Rugo HS; Im SA; Joy AA; Shparyk Y; Walshe JM; Sleckman B; Loi S; Theall KP; Kim S; Huang X; Bananis E; Mahtani R; Finn RS; Diéras V
Future Oncol; 2024 Jan; 20(1):5-16. PubMed ID: 37916267
[TBL] [Abstract] [Full Text] [Related]
6. Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative breast cancer.
Abduh MS
Int J Nanomedicine; 2023; 18():5713-5732. PubMed ID: 37849642
[TBL] [Abstract] [Full Text] [Related]
7. Cannabinoids and standardized cannabis extracts inhibit migration, invasion, and induce apoptosis in MCF-7 cells through FAK/MAPK/Akt/NF-κB signaling.
Suttithumsatid W; Sukketsiri W; Panichayupakaranant P
Toxicol In Vitro; 2023 Dec; 93():105667. PubMed ID: 37625625
[TBL] [Abstract] [Full Text] [Related]
8. Exploring the cross-cancer effect of smoking and its fingerprints in blood DNA methylation on multiple cancers: A Mendelian randomization study.
Zhou Y; Zhou X; Sun J; Wang L; Zhao J; Chen J; Yuan S; He Y; Timofeeva M; Spiliopoulou A; Mesa-Eguiagaray I; Farrington SM; Ding K; Dunlop MG; Qian X; Theodoratou E; Li X
Int J Cancer; 2023 Oct; 153(8):1477-1486. PubMed ID: 37449541
[TBL] [Abstract] [Full Text] [Related]
9. Understanding the Mechanism and Extent of Transplacental Transfer of (-)-∆
Kumar AR; Sheikh ED; Monson JW; Ligon SE; Talley RL; Dornisch EM; Howitz KJ; Damicis JR; Ieronimakis N; Unadkat JD
Clin Pharmacol Ther; 2023 Aug; 114(2):446-458. PubMed ID: 37278090
[TBL] [Abstract] [Full Text] [Related]
10. Zhuidu Formula suppresses the migratory and invasive properties of triple-negative breast cancer cells via dual signaling pathways of RhoA/ROCK and CDC42/MRCK.
Wu Q; Ma X; Jin Z; Ni R; Pan Y; Yang G
J Ethnopharmacol; 2023 Oct; 315():116644. PubMed ID: 37196814
[TBL] [Abstract] [Full Text] [Related]
11. Phytocannabinoids in Triple Negative breast cancer Treatment: Current Knowledge and Future Insights.
Bimonte S; Palma G; Cascella M; Cuomo A
Anticancer Res; 2023 Mar; 43(3):993-1000. PubMed ID: 36854495
[TBL] [Abstract] [Full Text] [Related]
12. Δ
Takeda S; Hirao-Suzuki M; Aramaki H; Watanabe K
Forensic Toxicol; 2023 Jul; 41(2):287-293. PubMed ID: 36583834
[TBL] [Abstract] [Full Text] [Related]
13. Maternal and Fetal Exposure to (-)-Δ
Chen X; Unadkat JD; Mao Q
Drug Metab Dispos; 2023 Mar; 51(3):269-275. PubMed ID: 36446608
[TBL] [Abstract] [Full Text] [Related]
14. Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (thc)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain.
Clarke S; Butcher BE; McLachlan AJ; Henson JD; Rutolo D; Hall S; Vitetta L
PLoS One; 2022; 17(10):e0270543. PubMed ID: 36240167
[TBL] [Abstract] [Full Text] [Related]
15. Antitumoral potential of Chartergellus-CP1 peptide from Chartergellus communis wasp venom in two different breast cancer cell lines (HR+ and triple-negative).
Soares S; Lopes KS; Mortari M; Oliveira H; Bastos V
Toxicon; 2022 Sep; 216():148-156. PubMed ID: 35839869
[TBL] [Abstract] [Full Text] [Related]
16. Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer.
Ong CHC; Lee DY; Lee B; Li H; Lim JCT; Lim JX; Yeong JPS; Lau HY; Thike AA; Tan PH; Iqbal J
Breast Cancer Res; 2022 Jun; 24(1):38. PubMed ID: 35659359
[TBL] [Abstract] [Full Text] [Related]
17. Macrophage mitochondrial fission improves cancer cell phagocytosis induced by therapeutic antibodies and is impaired by glutamine competition.
Li J; Ye Y; Liu Z; Zhang G; Dai H; Li J; Zhou B; Li Y; Zhao Q; Huang J; Feng J; Liu S; Ruan P; Wang J; Liu J; Huang M; Liu X; Yu S; Liang Z; Ma L; Gou X; Zhang G; Chen N; Lu Y; Di C; Xia Q; Pan J; Feng R; Cai Q; Su S
Nat Cancer; 2022 Apr; 3(4):453-470. PubMed ID: 35484420
[TBL] [Abstract] [Full Text] [Related]
18. 2',3',4'-Trihydroxychalcone changes estrogen receptor α regulation of genes and breast cancer cell proliferation by a reprogramming mechanism.
Herber CB; Yuan C; Chang A; Wang JC; Cohen I; Leitman DC
Mol Med; 2022 Apr; 28(1):44. PubMed ID: 35468719
[TBL] [Abstract] [Full Text] [Related]
19. Chitosan-coated nanostructured lipid carriers for transdermal delivery of tetrahydrocurcumin for breast cancer therapy.
Truong TH; Alcantara KP; Bulatao BPI; Sorasitthiyanukarn FN; Muangnoi C; Nalinratana N; Vajragupta O; Rojsitthisak P; Rojsitthisak P
Carbohydr Polym; 2022 Jul; 288():119401. PubMed ID: 35450653
[TBL] [Abstract] [Full Text] [Related]
20. Dynamic Enhanced Magnetic Resonance Imaging versus Ultrasonic Diffused Optical Tomography in Early Diagnosis of breast cancer.
Xue F; Jiang J
J Healthc Eng; 2022; 2022():4834594. PubMed ID: 35449832
[TBL] [Abstract] [Full Text] [Related]
[Next]
